Cite
HARVARD Citation
Codreanu, C. et al. (2018). Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis. Current medical research and opinion. pp. 1763-1769. [Online].